We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Ranbaxy Laboratories and GlaxoSmithKline (GSK) have entered into an agreement on generic Valtrex, Ranbaxy announced. As part of the settlement, Ranbaxy will launch its generic version of the blockbuster herpes drug in late 2009 with 180 days of market exclusivity.